Curable. Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	35,505

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 59.39

Current Ratio	59.39
Quick Ratio	59.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 4.99% and return on invested capital (ROIC) is 2.36%.

Return on Equity (ROE)	4.99%
Return on Assets (ROA)	2.19%
Return on Invested Capital (ROIC)	2.36%
Return on Capital Employed (ROCE)	3.46%
Revenue Per Employee	151.38M
Profits Per Employee	21.72M
Employee Count	16
Asset Turnover	0.32
Inventory Turnover	n/a

Taxes

In the past 12 months, Curable. has paid 82.04 million in taxes.

Income Tax	82.04M
Effective Tax Rate	19.10%

Stock Price Statistics

The stock price has decreased by -99.95% in the last 52 weeks. The beta is 0.26, so Curable.'s price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	-99.95%
50-Day Moving Average	28,405.28
200-Day Moving Average	63,375.82
Relative Strength Index (RSI)	29.84
Average Volume (20 Days)	4,230

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Curable. had revenue of KRW 2.42 billion and earned 347.47 million in profits.

Revenue	2.42B
Gross Profit	835.06M
Operating Income	262.59M
Pretax Income	429.51M
Net Income	347.47M
EBITDA	392.49M
EBIT	262.59M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 4.31 billion in cash and n/a in debt, giving a net cash position of 4.31 billion.

Cash & Cash Equivalents	4.31B
Total Debt	n/a
Net Cash	4.31B
Net Cash Per Share	n/a
Equity (Book Value)	7.14B
Book Value Per Share	n/a
Working Capital	4.38B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 418.13 million and capital expenditures -287.97 million, giving a free cash flow of 130.16 million.

Operating Cash Flow	418.13M
Capital Expenditures	-287.97M
Free Cash Flow	130.16M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 34.48%, with operating and profit margins of 10.84% and 14.35%.

Gross Margin	34.48%
Operating Margin	10.84%
Pretax Margin	17.73%
Profit Margin	14.35%
EBITDA Margin	16.20%
EBIT Margin	10.84%
FCF Margin	5.37%

Dividends & Yields

Curable. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 4, 2025. It was a reverse split with a ratio of 0.05.

Last Split Date	Jul 4, 2025
Split Type	Reverse
Split Ratio	0.05

Scores

Curable. has an Altman Z-Score of 1.69 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.69
Piotroski F-Score	5